Pages
Products
AAV2-CAG-Cre-GFP

AAV2-CAG-Cre-GFP

Cat.No. :  AAV00157Z

Titer: ≥1x10^12 GC/mL / ≥1x10^13 GC/mL Size: 30 ul/100 ul/500 ul/1 ml

Serotype:  AAV Serotype 2 Storage:  -80 ℃

Inquire for Price

AAV Particle Information

Quality Control

Cat. No. AAV00157Z
Description AAV serotype 2 particles contain Cre recombinase fused with GFP under CAG promoter.
Serotype AAV Serotype 2
Titer Varies lot by lot, typically ≥1x10^12 GC/mL
Size Varies lot by lot, for example, 30 μL, 50 μL, 100 μL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance.
Purity AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE.
Sterility The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities.
Empty vs. Full Capsids Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods.
Quick Inquiry

Background

Publications

Q & A

Customer Reviews

Adeno-associated virus serotype 2 (AAV-2) is a replication-deficient parvovirus that infects humans without producing significant pathology. The virus consists of a 5 kb single-stranded DNA genome contained within a nonenveloped icosahedral capsid. The virus is replication defective and requires coinfection with a helper virus such as adenovirus (Ad) or herpes simplex virus (HSV) for transmission. Several AAV serotypes have been studied for use as gene therapy vectors or recombinant vaccine vectors. Although AAV-2 has relatively little transgene cloning capacity, a number of properties make it an attractive gene therapy vector. The virus is able to transduce dividing and non-dividing cells in a variety of tissue types and is capable of defined integration on human chromosome 19, providing the opportunity for stable, controlled transgene expression. Finally, AAV-2 is thought to induce minimal host immune responses, possibly due to its dependence on helper viruses. The modest immune responses reported to date have suggested a reduced risk of vector or transduced cell destruction following administration.
Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Invaluable tool

Whether working with in vivo or in vitro models, the AAV2-CAG-Cre-GFP’s ability to target specific cellular populations without off-target effects has enabled a wide range of applications, from basic research to potential therapeutic explorations.

United States

05/31/2024

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction